Inovio Pharmaceuticals announces proposed public offering of common stock and warrants

Stock Information for Inovio Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Inovio Pharmaceuticals Inc.

INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)
INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025
INOVIO to Present at Upcoming Scientific Conference
INOVIO Announces Pricing of $25 Million Public Offering
INOVIO Announces Proposed Public Offering
Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development
INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.